AzTrials
AzTrials

AnesthesiaPhase 4NCT03087604

Loss of Resistance, w/wo Stimulation, For Epidural Placement

A Phase 4 study testing Thoracic epidural block, Electrical Nerve stimulation and Solution For Thoracic epidural block in people with Anesthesia, run by Wake Forest University Health Sciences at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this randomized, observer-blinded, investigative trial is to determine if the use of electrical stimulation, compared to the traditional loss of resistance technique alone, improves the success rate of epidural catheter placement at an academic teaching institution. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Anesthesia
What is being tested?
Thoracic epidural block, Electrical Nerve stimulation and Solution For Thoracic epidural block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
17 Mar 2017to 11 Oct 2017
Phase
Phase 4
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults undergoing intra-thoracic or intra-abdominal procedures that normally would receive thoracic epidurals for post-operative analgesia will be eligible.

Who cannot join

  • Subjects with contraindications to regional anesthesia:
  • history of allergy to amide local anesthetics
  • presence of a progressive neurological deficit
  • patients that are on anticoagulant medications that prohibit placement of an epidural
  • Systemic infection
  • Infection at the site of placement

Trial locations and contacts

1 site in 1 country.

United States1 site
  • WakeForestUBMC

    Winston-Salem, North Carolina, 27157

Other trials in United States

About this study

Official title: Loss of Resistance With Nerve Stimulation Versus Loss of Resistance Alone; Effect on Success of Thoracic Epidural Placement.

The purpose of this randomized, observer-blinded, investigative trial is to determine if the use of electrical stimulation, compared to the traditional loss of resistance technique alone, improves the success rate of epidural catheter placement at an academic teaching institution.

Read the detailed description

All subjects will receive a thoracic epidural catheter placement at the level appropriate for their surgery and will be randomized to either have the epidural placed with a loss of resistance technique alone or loss of resistance technique with confirmation by nerve stimulation. In the traditional loss of resistance technique group, the epidural catheter will be placed after achieving loss of resistance to air. In the electrical stimulation group, following the location of the epidural space with a loss of resistance technique (using air), nerve stimulation will be utilized to elicit a myotomal contraction of the abdominal or thoracic wall. Nerve stimulation will be started at a pulse width of 0.3 ms and a frequency of 1 Hz and a current of 0.2mA.

Conditions
Anesthesia
Being tested
Thoracic epidural block, Electrical Nerve stimulation, Solution For Thoracic epidural block
Keywords
epidural catheter placement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Thoracic epidural blockProcedure or surgery

    Thoracic epidural block with epidural placed with a loss of resistance technique alone.

  • Electrical Nerve stimulationProcedure or surgery

    In the electrical stimulation group, following the location of the epidural space with a loss of resistance technique (using air), nerve stimulation will be utilized to elicit a myotomal contraction of the abdominal or thoracic wall.stimulating peripheral nerve catheters(19 Ga. x 90 cm StimuCath® Continuous Nerve Block Catheter with SnapLock™ Adapter (Arrow by Teleflex Medical, Morrisville, NC), and stimulation will be achieved using a B Braun Stimuplex HNS12 Nerve Stimulator product id 4892098.

  • Solution For Thoracic epidural blockDrug

    Also called Lidocaine, Epinephrine

    Dose of 3+2 ml of 1.5% lidocaine with 1:200,000 epinephrine

Study groups in NCT03087604
Study groupRoleWhat they receive
Traditional Technique GroupActive comparatorIn the traditional loss of resistance technique group, the epidural catheter will be placed after achieving loss of resistance to air. After placement of the catheter a standard test dose of 3+2 ml of 1.5% lidocaine with 1:200,000 epinephrine will be administered.Solution for Thoracic epidural block.
Receives: Procedure: Thoracic epidural block; Drug: Solution For Thoracic epidural block
Electric Stimulation GroupExperimentalIn the electrical stimulation group, following the location of the epidural space with a loss of resistance technique (using air), nerve stimulation will be utilized to elicit a myotomal contraction of the abdominal or thoracic wall. After placement of the catheter a standard test dose of 3+2 ml of 1.5% lidocaine with 1:200,000 epinephrine will be administered.Solution for Thoracic epidural block.Thoracic epidural block with Electrical Nerve stimulation
Receives: Procedure: Thoracic epidural block; Procedure: Electrical Nerve stimulation; Drug: Solution For Thoracic epidural block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success Rate of Placement of a Thoracic Epidural

    will be determined by the detection of a loss of sensation to cold (ice) in at least two contiguous dermatomal levels, 15 minutes after administration of a test dose of lidocaine through the epidural catheter. If a loss of cold sensation is found, then the epidural placement will be classified as successful. If no loss of cold sensation is found, then the epidural placement will be classified as unsuccessful.

    Measured: 15 minutes after administration of a test dose of lidocaine

Secondary outcomes (2)
  1. Time Required to Place the Epidural Catheter

    The time required to place the epidural catheter will be recorded

    Measured: From the initiation of procedure to end of procedure

  2. Number of Thoracic Spine Levels Attempted

    the number of thoracic spine levels attempted will be recorded

    Measured: Thirty minutes after start of procedure.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Mar 2017
  2. Study start17 Mar 2017
  3. Primary completion11 Oct 2017
  4. Study completion11 Oct 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03087604
Sponsor's protocol ID
IRB00039522
Status last verified
Oct 2018
First submitted
3 Mar 2017
Last updated
17 Jun 2020
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Publications

  • Dobson SW, Weller RS, Edwards C, Turner JD, Jaffe JD, Reynolds JW, Henshaw DS. A randomized comparison of loss of resistance versus loss of resistance plus electrical stimulation: effect on success of thoracic epidural placement. BMC Anesthesiol. 2022 Feb 9;22(1):43. doi: 10.1186/s12871-022-01584-x.

    PubMed 35139802

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Thoracic epidural block, Electrical Nerve stimulation and Solution For Thoracic epidural block in people with Anesthesia, run by Wake Forest University Health Sciences at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 23 Nov 2018). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success Rate of Placement of a Thoracic Epidural (time frame: 15 minutes after administration of a test dose of lidocaine). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03087604, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in